Brain cancer patients at UHCW demand public inquiry into chemotherapy scandal

Brain cancer patients at UHCW demand public inquiry into chemotherapy scandal

A mother of two, now 34, shared her anguish over a devastating medical error that nearly prevented her from being there for her children’s future. She was just 21 when she was diagnosed with a grade 4 glioblastoma and given a prognosis of six to twelve months to live. However, after enduring over 100 cycles of chemotherapy, it was discovered that she had never had a brain tumor at all. Instead, her imaging results were consistent with tumefactive demyelination, a much less serious condition.

She expressed her disbelief and frustration following the release of a report commissioned by the NHS Trust responsible for her care, saying, “The findings are worse than I ever expected them to be.” She called for a national inquiry and systemic changes to prevent such errors from affecting others in the future. “I don’t think I’ll ever find closure until the Trust accept what they have done wrong and are held accountable. I would like answers.”

The report emerged after the retirement of a clinical oncologist at University Hospitals Coventry and Warwickshire (UHCW) NHS Trust, where the mistakes took place. Professor Brown, identified as Dr Y in the Royal College of Physicians (RCP) review, did not participate in the investigation and declined to comment when contacted. Meanwhile, the Trust issued a formal apology for the failures within its neuro-oncology service, with Chief Executive Professor Andy Hardy and Chair Sue Noyes stating, “This is far below the standards our patients deserve and that we expect. We let you down, and for that we offer our sincere apologies.”

A particular chemotherapy drug, TMZ (temozolomide), commonly prescribed for glioblastoma and astrocytoma brain tumors, is typically administered following radiotherapy for six cycles over about six months. However, the review uncovered cases where patients received this drug for years. Between 2017 and 2023, 83 patients were treated with extended TMZ, raising concerns about widespread harm. The RCP examined 20 specific cases linked to Prof Brown’s care but acknowledged that the overall number of affected individuals, including those who have passed away, is higher. The report recommended that any broader review of deceased patients given prolonged treatment should involve discussions with the Department of Health and Social Care due to the significant resources required.

Mark Poulton, a 54-year-old father of three from Redditch, described his own ordeal after undergoing chemotherapy for a decade under a misdiagnosis. He initially was told he had oligodendroglioma in 2014 but learned in 2024 that his actual condition was astrocytoma. Mark shared with the BBC, “I feel angry that I’ve gone through 10 years of TMZ that I probably shouldn’t have done and the report backs that.” He added, “You get a cancer diagnosis of any sort and you feel you will collapse, then you go to a hospital and you’re in the right place, you feel safe, only to find out 10 to 12 years later that you were abused by the system that failed me and the other patients involved.” Mark insists that the matter demands more than just a review, urging that steps must be taken “so it doesn’t happen again.”

The review also brought attention to the severe side effects experienced by some patients exposed to long-term chemotherapy, including an increased risk of secondary cancers and other serious health issues. One patient treated for 10 years suffered from ongoing fatigue, nausea, a severe episode of ophthalmic shingles, and galactorrhoea linked to anti-nausea medication. Furthermore, the document highlighted that patients were sometimes implicitly or explicitly pressured to continue treatment, with misleading information provided in certain cases. Some patients expressed a desire to stop chemotherapy, but evidence showed that these requests were either dismissed or unrecorded. In one instance, a patient was told by a clinical nurse that the oncologist was “legally bound” to continue treatment, underscoring a troubling lack of patient autonomy

Read the full article from The BBC here: Read More